201620172018201920202021202220232024Billable/Specific Code
- R59.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM R59.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of R59.0 – other international versions of ICD-10 R59.0 may differ.
ICD-10-CM R59.0 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to R59.0:
- inguinal > Adenopathy (lymph gland) R59.9
- localized > Adenopathy (lymph gland) R59.9
- mediastinal > Adenopathy (lymph gland) R59.9
- mesentery > Adenopathy (lymph gland) R59.9
- tracheobronchial > Adenopathy (lymph gland) R59.9
- localized > lymph gland or node R59.9
- cervical gland > Hyperplasia, hyperplastic
- localized > gland, glandular R59.9
- hilus gland > Hypertrophy, hypertrophic
- localized > lymph, lymphatic gland R59.9
- localized > Lymphadenopathy (generalized) R59.1
- cervical gland > Swelling (of) R60.9
- localized > glands R59.9